Medical bottles and syringes are seen with the logo of the new Nordisk shown on the screen in the background.
Nurphoto | Nurphoto | Getty Images
Stocks Novo Nordisk It fell on Monday, after a Danish pharmaceutical giant said her remedy for the weight loss of the next generation of weight loss medication helped adult obese or overweight with type 2 diabetes, 15.7% of their weight after 68 weeks.
The company’s shares fell for 5.52% at 11:10 pm in London.
This news of news is updated.
